Norgesic
Active substance: ORPHENADRINE CITRATE, ASPIRIN, CAFFEINE
TABLET · ORPHENADRINE CITRATE 25 mg/1, ASPIRIN 385 mg/1, CAFFEINE 30 mg/1
United StatesActive
Marketing holder: Galt Pharmaceuticals, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ORPHENADRINE CITRATE · 25 mg/1
- ASPIRIN · 385 mg/1
- CAFFEINE · 30 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8ec4-7f18-a6f3-28036444743f,01a1208c-d777-7e41-9d17-06973c481551,01a1208d-2938-7dc1-b081-bd5b7ad054ab,01a1208d-c8e8-7589-af12-fdb50499409f,01a1208d-d1e6-754f-a984-ed3bfc812829;count=20 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 61825-305
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 61825-305 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 61825-305 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 61825-305 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 61825-305 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 61825-305 · Verified 2026-10-09 · open in source